Press Releases

You Narrowed By: Business/Product Release

Showing 71-105 of 174


2012

April

April 9

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

April 4

Abbott to Present Positive Phase 2 Results from Multiple Interferon-Free Studies of Combination Regimens for the Treatment of Hepatitis C
 

March

March 30

Abbott's PLEX-ID Molecular System and Tests for Broad Microbial Identification Obtain CE Marking

March 21

Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company

March 20

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 15

Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA® (adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (Europe)

March 15

Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA® (adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (U.S.)

March 12

New Publication Presents Comparative Efficacy Data for Abbott's Zemplar® (paricalcitol) in Treating Secondary Hyperparathyroidism in Hemodialysis Patients

March 8

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance

March 7

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

March 6

Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy

March 5

Abbott to Collaborate on Rapid Molecular Test to Identify Serious Infections in Bones and Joint

March 2

Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence

March 1

Abbott to Build Nutrition Manufacturing Facility in Ohio
 

February

February 29

Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases

February 23

Abbott Collaborates with Leading U.S. Forensics Center on Human Identification Testing

February 17

Abbott Receives Positive Opinion for HUMIRA® in Ulcerative Colitis from EMA's CHMP

February 13

Study Shows Abbott's Tacrolimus Assay Demonstrates Consistent Organ Transplant Drug Monitoring

February 8

Abbott Creates New Similac SimplySmart™ Baby Bottle with Innovative Features

February 1

Abbott to Present at Leerink Swann 2012 Global Healthcare Conference
 

January

January 30

DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases

January 18

Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories

2011

December

December 22

Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease

December 8

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent
 

November

November 30

Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels

November 28

Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen

November 21

Abbott Introduces the First FDA-Approved Supplemental Blood Test for Chagas Disease

November 15

Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011

November 14

New Data Reinforce Clinical Performance of Abbott's ABSORB Bioresorbable Vascular Scaffold

November 9

Abbott Receives CE Mark for New Hepatitis Test

November 8

Abbott Reports Five-Year Data for HUMIRA® (Adalimumab) in Ankylosing Spondylitis

November 7

Abbott Presents HUMIRA® (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis

November 6

Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA

November 4

Abbott Announces Winners of "CFChef Challenge" Recipe Contest as Part of Online Nutrition Resource for People Affected by Cystic Fibrosis

November 3

Abbott to Present New Data for Key Vascular Products at TCT 2011